Patient Perspective on the Value of Biosimilars During IGBA #GlobalBiosimilarsWeek

Steve Selde, Director of the Biosimilars Council, a division of the Association of Accessible Medicines (AAM), joins Eileen to celebrate #GlobalBiosimilarsWeek and catch up with her since she last shared her biosimilar experience.

View Eileen's story on the AAM blog:

Learn more about the annual IGBA global education initiative at

If you are a patient, caregiver, or healthcare provider, you can also share your biosimilars story at


Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.